Kintor Pharmaceutical Limited lero yalengeza kuti kampaniyo yamaliza kulembetsa odwala 160 pagawo lachiwiri la mayeso achipatala a KX-826 ("pyrilutamide") ku China pochiza matenda a androgenetic alopecia (AGA) pa 4 Marichi 2022, omwe angotsala pang'ono. zatenga pafupifupi miyezi inayi chiyambireni kukhazikitsidwa kwake.
Chiwerengero cha anthu omwe ali ndi vuto la tsitsi chimakhala ndi chiwerengero chochuluka ndipo chimakhala chaching'ono, ndipo kutayika tsitsi pang'onopang'ono kumakhala cholinga cha anthu onse. Pofika kumapeto kwa 2020, kuchuluka kwa tsitsi ku China kudapitilira 252 miliyoni. AGA, yomwe imadziwika kuti mtundu wodziwika kwambiri wa kuthothoka tsitsi, ndi vuto lomwe lingakhudze amuna ndi akazi. Ku China, kuchuluka kwa AGA kuli pafupifupi 21.3% mwa amuna ndi 6.0% mwa akazi.
Dr. Youzhi Tong, woyambitsa, Wapampando, ndi CEO wa Kintor Pharma anati, "Ndife okondwa kuona kutha kwa kulembetsa maphunziro onse mu gawo lachiwiri la mayesero achipatala a KX-826, ndipo ndikufuna kuthokoza mwapadera kwa ofufuza onse, anthu ndi gulu langa omwe adachita nawo mayeso achipatala awa. Ku China, mmodzi mwa achikulire 20 aliwonse amadwala tsitsi, ndipo chiŵerengero cha amuna akuluakulu ndi 5:1. Tsitsi limakhudza kwambiri thanzi la odwala komanso moyo wabwino. Tikuyembekeza kulandira zoyambira kuchokera ku kafukufukuyu mu Q4 chaka chino, kukulitsa kuthekera kwachipatala kwa KX-826 mwa odwala AGA azimayi, ndikufulumizitsa kuyesa kwachipatala kwa KX-826's phase III kwa odwala AGA achimuna ku China, kuti tikwaniritse chithandizo cha anthu omwe akudwala tsitsi posachedwa. ”
Mayesero a Gawo II ndi kufufuza kosasinthika, kosaoneka kawiri, koyendetsedwa ndi placebo, kumadera ambiri kuti awone momwe KX-826 imathandizira ndi chitetezo cha AGA mwa akazi akuluakulu (N = 160).